Home
About
The Themis Story
About Us
The Themis Group
Our Milestones
Certifications
From The CEO’s Desk
The Board
The Management Committees
Our Presence
Domestic
International
Business Partners
Products
Star Products
Differential Products
Therapeutics Area
APIs
Innovations
R&D Breakthroughs
Product In Pipeline
Our Inventions
Manufacturing
Plant Information
QA & RA
EHS Support
Media
Events
News & Announcement
Social Responsibility
Careers
Life at Themis
Current Openings
Contact
Head Office
Manufacturing Facilities
Investor Relations
Annual Report
Financial Results
Share Holding Pattern
Notice to Members
Policies and Codes
Audited Results of Subsidiaries
Unclaimed Dividend and Shares
Investor News
Press Releases
Miscellaneous
Stock Update
Investor Service Contact
Stock Price:
BSE
|
NSE
Investor News
- 2019-20
View:
2019-20
Intimation of Board Meeting to be held on 07.02.2020
Intimation of Closing of trading window in terms of SEBI (PIT) Regulations, 2015
Grant of Options under 'THEMIS MEDICARE ESOS 2012'
Outcome of Board Meeting 2019
Newspaper Advertisement pursuant to Regulation 47 of SEBI
Intimation of Board Meeting to be held on 14 Nov 2019
Reply to Clarification sought by BSE on Price Movement
Reply to Clarification sought by NSE on price movement
Outcome of Board Meeting
Closure of trading window Aug meeting
Disclosure under Reg 30 - Update on Litigation
Notice of Board Meeting Aug 2019
Update of Litigation Disclosure to Stock Exchanges under Reg 30
Intimation to Stock Exchange under Regulation 29(9) - RPTs
Submission of Annual Secretarial Compliance Certificate
TML Outcome of Board meeting
Newspaper Notice to Stock Exchanges
Notice of BM May 2019
Initial Disclosure to be made by an entity identified as a Large Entity - TML
Certificate under Regulation 74(5) for the Qtr. ended 31 March 2019
BSE and NSE - Disclosure - Reg 39(3)
Home
Investor Relations
Investor News